Astrazeneca Pharma India Ltd Corporate Actions

6,624.45
(-0.39%)
Dec 13, 2024|03:31:08 PM

CORPORATE ACTIONS

15/12/2023calendar-icon
14/12/2024calendar-icon

25 Oct 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

27 May 2024

12:00 AM

Dividend

Dividend Amount: 24

Record Date: 05 Jul, 2024

arrow

16 Jul 2024

12:00 AM

AGM

Announcement Date: 16 Jul, 2024

arrow

Astrazeneca Phar: Related News

AstraZeneca Pharma India Gets CDSCO Nod for Lynparza Cancer Drug
26 Nov 2024|11:42 PM

It is used with Durvalumab to treat advanced or recurrent endometrial cancer in patients whose disease has not progressed after first-line treatment.

Read More
AstraZeneca to introduce COPD inhaler Breztri Aerosphere in India
19 Nov 2024|09:50 AM

This combination drug is used to treat chronic obstructive pulmonary disease (COPD) in adults, relieving symptoms and preventing exacerbations.

Read More
AstraZeneca India Posts 31% Revenue Surge in Q2
14 Nov 2024|10:48 AM

For the first half (H1) of FY25, the revenue rose to ₹795.5 Crore, driven by growth in oncology, biopharmaceuticals, and rare disease segments.

Read More
AstraZeneca Pharma Surges on CDSO Approval for Durvalumab in India
24 Sep 2024|06:20 PM

The company plans to launch Durvalumab in 120 mg/2.4 mL and 500 mg/10 mL solutions in India, pending statutory approvals.

Read More
AstraZeneca Pharma gets approval to launch cancer drug in India
24 Sep 2024|10:54 AM

The said indication is for the use of durvalumab in combination with chemotherapy as a neoadjuvant treatment.

Read More
Top 10 stocks for today - 24th September 2024
24 Sep 2024|09:00 AM

Here are some of the stocks that may see significant price movement today: Punjab National Bank, NTPC, Power Grid, etc.

Read More
Cancer Patients Benefit as GST on Medications Slashed
10 Sep 2024|12:22 PM

The plan to reduce the GST on these drugs aims to significantly reduce the overall cost of cancer treatment.

Read More
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2024, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp